The test will help identify prone patients and provide them with preventive treatment
Scientists from the United States have developed a simple blood test capable, according to them, of identifying with a high degree of accuracy subjects who are expected to develop Alzheimer's disease within two or three years.
The researchers, from Georgetown University, followed for 5 years the condition of 525 participants in the experiment, all over 70 years old. About a tenth of the trial participants developed cognitive disorders during it, and the researchers discovered lower levels of certain fatty acids in their blood, compared to blood tests of participants who maintained normal brain functions.
The researchers point out that such a test will help identify susceptible patients and provide them with treatment that will prevent or delay the development of the disease.
